Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
35.33
+0.05 (0.14%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Assembly Biosciences Employees
Assembly Biosciences had 73 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
73
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,025,274
Profits / Employee
-$575
Market Cap
719.34M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Phathom Pharmaceuticals | 371 |
| Allogene Therapeutics | 152 |
| Scribe Therapeutics | 89 |
| OmniAb | 89 |
| BridgeBio Oncology Therapeutics | 88 |
| CytomX Therapeutics | 69 |
| Crescent Biopharma | 69 |
ASMB News
- 9 days ago - Assembly Biosciences reports Q2 EPS (20c), consensus (52c) - TheFly
- 12 days ago - Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates - GlobeNewsWire
- 13 days ago - Assembly Biosciences Quarterly report: Q2 2026 - Filings
- 13 days ago - Assembly Biosciences Earnings release: Q2 2026 - Filings
- 24 days ago - Assembly Biosciences Slides: Corporate presentation - Filings
- 2 months ago - Assembly Biosciences price target raised to $45 from $40 at Mizuho - TheFly
- 2 months ago - Assembly Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Assembly Biosciences Transcript: AGM 2026 - Transcripts